FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:356 July 31, 1997 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100% of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Ridker, P. M.

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men . On page 974, the sentence that begins in line 13 under the heading "Laboratory Analysis" should have read, "The C-reactive protein assay was standardized according to the WHO First International Reference Standard and had a sensitivity of 0.08 µg per milliliter," not "0.08 µg per microliter," as printed.

This article has been cited by other articles:

• Lowe, G. D.O., Rumley, A., McMahon, A. D., Ford, I., O'Reilly, D. St. J., Packard, C. J., for the West of Scotland Coronary Prevention Study, (2004). Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease. Arterioscler. Thromb. Vasc. Bio. 24: 1529-1534 [Abstract] [Full Text]  
• Sesmilo, G., Fairfield, W. P., Katznelson, L., Pulaski, K., Freda, P. U., Bonert, V., Dimaraki, E., Stavrou, S., Vance, M. L., Hayden, D., Klibanski, A. (2002). Cardiovascular Risk Factors in Acromegaly before and after Normalization of Serum IGF-I Levels with the GH Antagonist Pegvisomant. J. Clin. Endocrinol. Metab. 87: 1692-1699 [Abstract] [Full Text]  
• Lindmark, E., Diderholm, E., Wallentin, L., Siegbahn, A. (2001). Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery Disease: Effects of an Early Invasive or Noninvasive Strategy. JAMA 286: 2107-2113 [Abstract] [Full Text]  
• Gum, P. A., Thamilarasan, M., Watanabe, J., Blackstone, E. H., Lauer, M. S. (2001). Aspirin Use and All-Cause Mortality Among Patients Being Evaluated for Known or Suspected Coronary Artery Disease: A Propensity Analysis. JAMA 286: 1187-1194 [Abstract] [Full Text]  
• Erlinger, T. P., Guallar, E., Miller III, E. R., Stolzenberg-Solomon, R., Appel, L. J. (2001). Relationship Between Systemic Markers of Inflammation and Serum {beta}-Carotene Levels. Arch Intern Med 161: 1903-1908 [Abstract] [Full Text]  
• Lemieux, I., Pascot, A., Prud'homme, D., Almeras, N., Bogaty, P., Nadeau, A., Bergeron, J., Despres, J.-P. (2001). Elevated C-Reactive Protein : Another Component of the Atherothrombotic Profile of Abdominal Obesity. Arterioscler. Thromb. Vasc. Bio. 21: 961-967 [Abstract] [Full Text]  
• Stenestrand, U., Wallentin, L., for the Swedish Register of Cardiac Intensive Care, (2001). Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival. JAMA 285: 430-436 [Abstract] [Full Text]  
• Barron, H. V., Cannon, C. P., Murphy, S. A., Braunwald, E., Gibson, C. M. (2000). Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction : A Thrombolysis In Myocardial Infarction 10 Substudy. Circulation 102: 2329-2334 [Abstract] [Full Text]  
• Torzewski, M., Rist, C., Mortensen, R. F., Zwaka, T. P., Bienek, M., Waltenberger, J., Koenig, W., Schmitz, G., Hombach, V., Torzewski, J. (2000). C-Reactive Protein in the Arterial Intima : Role of C-Reactive Protein Receptor-Dependent Monocyte Recruitment in Atherogenesis. Arterioscler. Thromb. Vasc. Bio. 20: 2094-2099 [Abstract] [Full Text]